SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001549595-24-000120
Filing Date
2024-09-05
Accepted
2024-09-05 07:01:49
Documents
51
Period of Report
2024-09-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrix-20240905.htm   iXBRL 8-K 28124
2 EX-99.1 nurixtherapeuticsinvesto.htm EX-99.1 41442
6 nurixtherapeuticsinvesto001.jpg GRAPHIC 53083
7 nurixtherapeuticsinvesto002.jpg GRAPHIC 277416
8 nurixtherapeuticsinvesto003.jpg GRAPHIC 163307
9 nurixtherapeuticsinvesto004.jpg GRAPHIC 85103
10 nurixtherapeuticsinvesto005.jpg GRAPHIC 111348
11 nurixtherapeuticsinvesto006.jpg GRAPHIC 96581
12 nurixtherapeuticsinvesto007.jpg GRAPHIC 43949
13 nurixtherapeuticsinvesto008.jpg GRAPHIC 109935
14 nurixtherapeuticsinvesto009.jpg GRAPHIC 123498
15 nurixtherapeuticsinvesto010.jpg GRAPHIC 141224
16 nurixtherapeuticsinvesto011.jpg GRAPHIC 122395
17 nurixtherapeuticsinvesto012.jpg GRAPHIC 105468
18 nurixtherapeuticsinvesto013.jpg GRAPHIC 148831
19 nurixtherapeuticsinvesto014.jpg GRAPHIC 115699
20 nurixtherapeuticsinvesto015.jpg GRAPHIC 123824
21 nurixtherapeuticsinvesto016.jpg GRAPHIC 100921
22 nurixtherapeuticsinvesto017.jpg GRAPHIC 114832
23 nurixtherapeuticsinvesto018.jpg GRAPHIC 119201
24 nurixtherapeuticsinvesto019.jpg GRAPHIC 144753
25 nurixtherapeuticsinvesto020.jpg GRAPHIC 100032
26 nurixtherapeuticsinvesto021.jpg GRAPHIC 64184
27 nurixtherapeuticsinvesto022.jpg GRAPHIC 126129
28 nurixtherapeuticsinvesto023.jpg GRAPHIC 106710
29 nurixtherapeuticsinvesto024.jpg GRAPHIC 113822
30 nurixtherapeuticsinvesto025.jpg GRAPHIC 97032
31 nurixtherapeuticsinvesto026.jpg GRAPHIC 64281
32 nurixtherapeuticsinvesto027.jpg GRAPHIC 87126
33 nurixtherapeuticsinvesto028.jpg GRAPHIC 83778
34 nurixtherapeuticsinvesto029.jpg GRAPHIC 110035
35 nurixtherapeuticsinvesto030.jpg GRAPHIC 115912
36 nurixtherapeuticsinvesto031.jpg GRAPHIC 118285
37 nurixtherapeuticsinvesto032.jpg GRAPHIC 101233
38 nurixtherapeuticsinvesto033.jpg GRAPHIC 163401
39 nurixtherapeuticsinvesto034.jpg GRAPHIC 121346
40 nurixtherapeuticsinvesto035.jpg GRAPHIC 129168
41 nurixtherapeuticsinvesto036.jpg GRAPHIC 115285
42 nurixtherapeuticsinvesto037.jpg GRAPHIC 26650
  Complete submission text file 0001549595-24-000120.txt   5926077

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nrix-20240905.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nrix-20240905_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nrix-20240905_pre.xml EX-101.PRE 13046
53 EXTRACTED XBRL INSTANCE DOCUMENT nrix-20240905_htm.xml XML 2824
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 001-39398 | Film No.: 241279915
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)